Skip to content

The Presence of Microbes in the Sperm and Their Impact on Sperm Capacitation and IVF Treatment

The Presence of Microbes in the Sperm and Their Impact on Sperm Capacitation and IVF Treatment

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02585297
Enrollment
200
Registered
2015-10-23
Start date
2015-10-31
Completion date
Unknown
Last updated
2015-10-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility

Brief summary

Study Goals: 1. Finding the prevalence of bacteria of the sperm in an innovative and more accurate methode 2. Understanding the effect of microbes on the process of capacitation 3. The impact of microbes in the sperm on IVF success rate 4. Finding the incidence of vaginal bacteria and their relationship to bacteria of the sperm 5. The impact of vaginal flora on IVF success rate

Detailed description

Prospective non interventional study in the Department of Life Sciences, Bar-Ilan University and IVF Unit at Meir Hospital. The control group consisting of 50 semen samples from men with no sperm problems and 50 vaginal samples from their partners. The study group consisting of 50 semen samples from men with male fertility problems and 50 vaginal samples from their partners. The semen taken from the remains after fertilization of the IVF laboratory. (Liquid otherwise routinely thrown). Vaginal samples taken from women undergoing IVF treatment under anesthesia after informed consent. Enrollment also collect the following data: age, race, chronic illnesses, past surgeries and former fertility treatments. Data will be collected through anamnesis of the patient or the medical file after consent.

Interventions

OTHERno intervention

Sponsors

Meir Medical Center
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Male and female undergoing fertility treatments

Exclusion criteria

* Male and female not undergoing fertility treatments

Design outcomes

Primary

MeasureTime frameDescription
The percent of successful IFV treatments24 monthsUsing 16-S Ribosomal RNA analysis to quantify and compare (type and percentages) of bacterial components in sperm samples from fertile and infertile men and their impact on IVF treatments success rate

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026